Patients who had more severe geographic atrophy (GA) at baseline had greater healthcare resource utilization (HCRU) and outpatient costs, according to a study.
In this retrospective analysis, disease-specific HCRU and costs by disease severity were assessed for 28,773 patients with GA; 24% of patients had unilateral GA and 76% had bilateral GA.
Patients in the bilateral group with greater baseline severity had a significantly higher number of outpatient (OP) visits per year.
In the outpatient setting, higher patient-related costs were associated with increasing disease severity, and higher payer-related costs were seen in patients with bilateral GA without subfoveal involvement compared to bilateral early or intermediate AMD ($280 vs $198).
The authors concluded that “Further research should explore specific contributing factors to the long-term economic burden of GA.”
Reference
Kim A, Devine B, Campbell J, et al. Healthcare resource utilization and costs in patients with geographic atrophy secondary to age-related macular degeneration. Clin Ophthalmol. 2021;15:2643-2651. https://doi.org/10.2147/OPTH.S307603
This content is independent editorial sponsored by Astellas. Astellas had no input in the development of this content.
Related Content
